DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction

Clinical trial NCT05764057 · RECRUITING

Trial details

NCT number: NCT05764057
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

AMI STEMI NSTEMI Left Ventricular Dysfunction

Start date: 2023-06-12
Primary completion: 2026-10-12
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.